Aberrant expression of microRNA biosynthetic pathway components is a common feature of haematological malignancy.
Lawrie
Charles H
CH
Lymphoid Malignancy Research Group, Nuffield Department of Clinical Laboratory Sciences, University of Oxford, Oxford, UK. charles.lawrie@ndcls.ox.ac.uk
Cooper
Christopher D O
CD
Ballabio
Erica
E
Chi
Jianxiang
J
Tramonti
Daniela
D
Hatton
Christian S R
CS
D001402:B-Lymphocytes / Q000378:metabolism; D016022:Case-Control Studies; D002460:Cell Line; D015972:Gene Expression Regulation, Neoplastic; D019337:Hematologic Neoplasms / Q000378:metabolism*; D006801:Humans; D035683:MicroRNAs / Q000096:biosynthesis*; D043244:Ribonuclease III / Q000235:genetics; D013601:T-Lymphocytes / Q000378:metabolism
D035683:MicroRNAs; C517918:DROSHA protein, human; D043244:Ribonuclease III